Cargando…

Correlation of Aminoglycoside Consumption and Amikacin- or Gentamicin-Resistant Pseudomonas aeruginosa in Long-Term Nationwide Analysis: Is Antibiotic Cycling an Effective Policy for Reducing Antimicrobial Resistance?

Detalles Bibliográficos
Autores principales:	Kim, Young Ah, Park, Yoon Soo, Youk, Taemi, Lee, Hyukmin, Lee, Kyungwon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Laboratory Medicine 2018
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736680/ https://www.ncbi.nlm.nih.gov/pubmed/29214765 http://dx.doi.org/10.3343/alm.2018.38.2.176

Ejemplares similares

Trends in South Korean antimicrobial use and association with changes in Escherichia coli resistance rates: 12-year ecological study using a nationwide surveillance and antimicrobial prescription database
por: Kim, Young Ah, et al.
Publicado: (2018)

Abrupt Increase in Rate of Imipenem Resistance in Acinetobacter baumannii Complex Strains Isolated from General Hospitals in Korea and Correlation With Carbapenem Administration During 2002–2013
por: Kim, Young Ah, et al.
Publicado: (2018)

Changes in Antimicrobial Usage Patterns in Korea: 12-Year Analysis Based on Database of the National Health Insurance Service-National Sample Cohort
por: Kim, Young Ah, et al.
Publicado: (2018)

Glucose-Potentiated Amikacin Killing of Cefoperazone/Sulbactam Resistant Pseudomonas aeruginosa
por: Tang, Xi-kang, et al.
Publicado: (2022)

Efficacy of intraventricular amikacin treatment in pan-resistant Pseudomonas aeruginosa postsurgical meningitis
por: Molinaro, Mariadelfina, et al.
Publicado: (2018)

Effect of Imipenem and Amikacin Combination against Multi-Drug Resistant Pseudomonas aeruginosa
por: Farhan, Sara Mahmoud, et al.
Publicado: (2021)

AMINOGLYCOSIDE RESISTANCE GENES IN Pseudomonas aeruginosa ISOLATES FROM CUMANA, VENEZUELA
por: TEIXEIRA, Bertinellys, et al.
Publicado: (2016)

Structure of Pseudomonas aeruginosa ribosomes from an aminoglycoside-resistant clinical isolate
por: Halfon, Yehuda, et al.
Publicado: (2019)

Risk Factors for Acquisition of Fluoroquinolone or Aminoglycoside Resistance in Addition to Carbapenem Resistance in Pseudomonas aeruginosa
por: Kosai, Kosuke, et al.
Publicado: (2018)

Risk Factors for Acquisition of Fluoroquinolone or Aminoglycoside Resistance in Addition to Carbapenem Resistance in Pseudomonas Aeruginosa
por: Kosai, Kosuke, et al.
Publicado: (2017)

Role of Aminoglycoside-Modifying Enzymes (AMEs) in Resistance to Aminoglycosides among Clinical Isolates of Pseudomonas aeruginosa in the North of Iran
por: Ahmadian, Leila, et al.
Publicado: (2021)

Optimizing Doses of Ceftolozane/Tazobactam as Monotherapy or in Combination with Amikacin to Treat Carbapenem-Resistant Pseudomonas aeruginosa
por: Nasomsong, Worapong, et al.
Publicado: (2022)

In vitro potency of amikacin against carbapenem-resistant Pseudomonas aeruginosa: A target for nebulization strategy?
por: Cuba, Gabriel T., et al.
Publicado: (2022)

In Vitro Synergistic Effects of Antimicrobial Combinations on Extensively Drug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Isolates
por: Lee, Hyukmin, et al.
Publicado: (2016)

MexY-Promoted Aminoglycoside Resistance in Pseudomonas aeruginosa: Involvement of a Putative Proximal Binding Pocket in Aminoglycoside Recognition
por: Lau, Calvin Ho-Fung, et al.
Publicado: (2014)

Morphological and Bactericidal Effects of Amikacin, Meropenem and Imipenem on Pseudomonas aeruginosa
por: Moghoofei, Mohsen, et al.
Publicado: (2015)

Aminoglycoside-Modifying Enzymes Are Sufficient to Make Pseudomonas aeruginosa Clinically Resistant to Key Antibiotics
por: Thacharodi, Aswin, et al.
Publicado: (2022)

Characteristics of Metallo-β-Lactamase-Producing Pseudomonas aeruginosa in Korea
por: Hong, Jun Sung, et al.
Publicado: (2015)

Genome-Scale Identification Method Applied to Find Cryptic Aminoglycoside Resistance Genes in Pseudomonas aeruginosa
por: Struble, Julie M., et al.
Publicado: (2009)

Triclosan depletes the membrane potential in Pseudomonas aeruginosa biofilms inhibiting aminoglycoside induced adaptive resistance
por: Maiden, Michael M., et al.
Publicado: (2020)

Genomics of Aminoglycoside Resistance in Pseudomonas aeruginosa Bloodstream Infections at a United States Academic Hospital
por: Atassi, Giancarlo, et al.
Publicado: (2023)

Further Increases in Carbapenem-, Amikacin-, and Fluoroquinolone-Resistant Isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR Study 2009
por: Lee, Kyungwon, et al.
Publicado: (2011)

The comparative effects of erythromycin and amikacin on acute respiratory Pseudomonas aeruginosa infection
por: Yazdanian, Mohsen, et al.
Publicado: (2022)

Therapeutic monitoring of amikacin and gentamicin in critically and noncritically ill patients
por: Kovačević, Tijana, et al.
Publicado: (2016)

In Vitro Antibacterial Interaction of Doripenem and Amikacin against Multidrug-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae Isolates
por: Loho, Tonny, et al.
Publicado: (2018)

Ceftazidime-avibactam and intrapleural amikacin therapy for extensively drug-resistant Pseudomonas aeruginosa thoracic empyema: A case report
por: Chen, Tzu-Ting, et al.
Publicado: (2022)

Prevalence of resistance to aminoglycosides and fluoroquinolones among Pseudomonas aeruginosa strains in a University Hospital in Northeastern Poland
por: Michalska, Anna Diana, et al.
Publicado: (2015)

Impact of the Epithelial Lining Fluid Milieu on Amikacin Pharmacodynamics Against Pseudomonas aeruginosa
por: Heffernan, Aaron J., et al.
Publicado: (2021)

The Efficacy of Colistin Combined with Amikacin or Levofloxacin against Pseudomonas aeruginosa Biofilm Infection
por: Wang, Yuhang, et al.
Publicado: (2022)

Hypertonic saline enhances the efficacy of aerosolized gentamicin against Pseudomonas aeruginosa
por: Lin, Hui-Ling, et al.
Publicado: (2020)

Synergistic Effects of Gentamicin, Cefepime, and Ciprofloxacin on Biofilm of Pseudomonas aeruginosa
por: Usman, Muhammad, et al.
Publicado: (2023)

Mutation to ispA Produces Stable Small-Colony Variants of Pseudomonas aeruginosa That Have Enhanced Aminoglycoside Resistance
por: Pitton, Melissa, et al.
Publicado: (2022)

Pseudomonas aeruginosa in the ICU: prevalence, resistance profile, and antimicrobial consumption
por: Ribeiro, Ághata Cardoso da Silva, et al.
Publicado: (2019)

Tobramycin and Amikacin Delay Adhesion and Microcolony Formation in Pseudomonas aeruginosa Cystic Fibrosis Isolates
por: Olivares, Elodie, et al.
Publicado: (2017)

The predictive potential of different molecular markers linked to amikacin susceptibility phenotypes in Pseudomonas aeruginosa
por: Nageeb, Wedad M., et al.
Publicado: (2022)

In vivo Host Environment Alters Pseudomonas aeruginosa Susceptibility to Aminoglycoside Antibiotics
por: Pan, Xiaolei, et al.
Publicado: (2017)

4F-Indole Enhances the Susceptibility of Pseudomonas aeruginosa to Aminoglycoside Antibiotics
por: Dou, Qin, et al.
Publicado: (2023)

An usual approach to treatment of a case of multidrug resistance Pseudomonas aeruginosa peritonitis: parenteral and intraperitoneal aminoglycosides and parenteral colistin
por: May, Ian, et al.
Publicado: (2012)

Berberine Is a Novel Type Efflux Inhibitor Which Attenuates the MexXY-Mediated Aminoglycoside Resistance in Pseudomonas aeruginosa
por: Morita, Yuji, et al.
Publicado: (2016)

The Comparative Effectiveness of Ceftolozane/Tazobactam versus Aminoglycoside- or Polymyxin-Based Regimens in Multi-Drug-Resistant Pseudomonas aeruginosa Infections
por: Caffrey, Aisling R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sv599lfe8v7vn0dh1sm1s87ebm